Literature DB >> 25342491

Interaction between Pro12Ala polymorphism of PPARγ2 and diet on adiposity phenotypes.

Emanuela Lapice1, Olga Vaccaro.   

Abstract

The aim of this report is to perform a systematic review and qualitative synthesis of the literature to address whether, and to what extent, diet modulates the effects of the Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 (PPARγ2) on body weight and other measures of adiposity. A systematic search of the literature was conducted, wherein both observational and experimental studies of adults were reviewed. Overall, the results of the observational studies show little consistency. Methodological differences in their design, conduct and analysis may largely account for the apparently discrepant findings. This notwithstanding, the main picture that emerges is that the energy content and composition of the diet may affect BMI, body composition and metabolic parameters in Ala allele carriers more than in Pro/Pro homozygotes. In most studies, carriers of the Ala allele with an obesogenic lifestyle (i.e. high-energy, high-carbohydrate and, to some extent, high-fat diets) are more obese than Pro homozygotes. Well-designed intervention studies with a sufficiently large sample size consistently show that carriers of the Ala allele are more prone to weight loss when exposed to a healthy lifestyle; however, these individuals do not seem to retain these benefits when returning to a sedentary lifestyle and inadequate dieting behaviours. Some key questions in this area of research have emerged. Carefully designed and adequately powered studies are needed, particularly involving the development and validation of standardized tools for the assessment of dietary exposure, including the use of biomarkers, to move the field forward.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25342491     DOI: 10.1007/s11883-014-0462-9

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  35 in total

Review 1.  Obesity--is it a genetic disorder?

Authors:  R J F Loos; C Bouchard
Journal:  J Intern Med       Date:  2003-11       Impact factor: 8.989

Review 2.  The many faces of PPARgamma.

Authors:  Michael Lehrke; Mitchell A Lazar
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

3.  Genes, fat intake, and cardiovascular disease risk factors in the Quebec Family Study.

Authors:  Julie Robitaille; Louis Pérusse; Claude Bouchard; Marie-Claude Vohl
Journal:  Obesity (Silver Spring)       Date:  2007-09       Impact factor: 5.002

4.  Evidence for gene-nutrient interaction at the PPARgamma locus.

Authors:  J Luan; P O Browne; A H Harding; D J Halsall; S O'Rahilly; V K Chatterjee; N J Wareham
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

Review 5.  The many faces of diabetes: a disease with increasing heterogeneity.

Authors:  Tiinamaija Tuomi; Nicola Santoro; Sonia Caprio; Mengyin Cai; Jianping Weng; Leif Groop
Journal:  Lancet       Date:  2013-12-03       Impact factor: 79.321

6.  Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects.

Authors:  Kil Soo Kim; Sun Mi Choi; Seung Uoo Shin; Hyun Sung Yang; Yoosik Yoon
Journal:  Metabolism       Date:  2004-12       Impact factor: 8.694

7.  Lifestyle factors modify obesity risk linked to PPARG2 and FTO variants in an elderly population: a cross-sectional analysis in the SUN Project.

Authors:  Cecilia Galbete; Jon Toledo; Miguel Angel Martínez-González; J Alfredo Martínez; Francisco Guillén-Grima; Amelia Marti
Journal:  Genes Nutr       Date:  2012-04-24       Impact factor: 5.523

8.  Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms.

Authors:  Estibaliz Goyenechea; M Dolores Parra; J Alfredo Martínez
Journal:  Br J Nutr       Date:  2006-11       Impact factor: 3.718

9.  Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.

Authors:  Virpi I Lindi; Matti I J Uusitupa; Jaana Lindström; Anne Louheranta; Johan G Eriksson; Timo T Valle; Helena Hämäläinen; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Markku Laakso; Jaakko Tuomilehto
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

Review 10.  Gene-environment interactions and the etiology of common complex disease.

Authors:  Richard S Cooper
Journal:  Ann Intern Med       Date:  2003-09-02       Impact factor: 25.391

View more
  4 in total

1.  The Single Nucleotide Polymorphism PPARG2 Pro12Ala Affects Body Mass Index, Fat Mass, and Blood Pressure in Severely Obese Patients.

Authors:  Ana Paula Dos Santos Rodrigues; Lorena Pereira Souza Rosa; Hugo Delleon da Silva; Elisângela de Paula Silveira-Lacerda; Erika Aparecida Silveira
Journal:  J Obes       Date:  2018-12-12

2.  Metabolomic Profiling of Aqueous Humor and Plasma in Primary Open Angle Glaucoma Patients Points Towards Novel Diagnostic and Therapeutic Strategy.

Authors:  Yizhen Tang; Yiqiong Pan; Yuhong Chen; Xiangmei Kong; Junyi Chen; Hengli Zhang; Guangxian Tang; Jihong Wu; Xinghuai Sun
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

3.  Relationship of the Pro12Ala Polymorphism on the PPARy2 Gene With the Body Composition of Practitioners of Cyclic Exercises.

Authors:  Raquel Suelen Brito da Silva; Darlene Camati Persuhn; Francisca Karinny Lemos Barbosa; Marizângela Ferreira de Souza; Klécia de Farias Sena; Matheus da Silveira Costa; Gisele Augusta Maciel Franca; Caroline Severo de Assis; Glêbia Alexa Cardoso; Alexandre Sérgio Silva
Journal:  Front Physiol       Date:  2021-01-12       Impact factor: 4.566

4.  PPARG2 Pro12Ala polymorphism influences body composition changes in severely obese patients consuming extra virgin olive oil: a randomized clinical trial.

Authors:  Ana Paula Santos Rodrigues; Lorena Pereira Souza Rosa; Erika Aparecida Silveira
Journal:  Nutr Metab (Lond)       Date:  2018-07-17       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.